Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Fluent™ – the new laboratory automation solution for cell-based assays from Tecan

Product Image
Product Description

Tecan has introduced the Fluent™ laboratory automation solution, the latest addition to its world-class laboratory automation portfolio. Fluent is a unique automation concept built around the application-specific needs of laboratories, delivering more capacity and increased speed. Initially focusing on the complete automation of cell-based and biochemical assay workflows, Fluent brings together all the modules and devices required for automation of these assays in a single efficient and easy-to-use platform.

The Fluent solution for cell-based assays is designed to take the complexity out of cell biology research. Tecan has partnered with a number of experts in cell-based assays – including HTRF® technology supplier Cisbio Bioassays, market leader in GPCR assays DiscoveRx, and leading contract research organization European ScreeningPort – to ensure exceptional versatility, walkaway operation and robust data. The result is a compact system that offers higher throughput, greater precision and excellent reliability, allowing researchers to concentrate on what really matters – the results.  

                                   Venue_resized.gif

Completely new from the ground up, Fluent is available in three sizes – offering deck capacities from 30 to 72 microplates – to suit the throughput requirements of almost any laboratory. The patented Dynamic Deck™ uses a modular, multi­level design to offer exceptional deck capacity, allowing flexible integration of all the complementary devices required for cell-based research – including incubators, washers and readers – into a single, fully automated system.

Developed to meet the everyday challenges faced by cell biology laboratories, Fluent aims to make cell-based assay workflows faster and more efficient. Liquid handling and labware logistics have never been easier, thanks to the instrument’s three, task-specific arms which operate simultaneously to ensure timely completion of assays, minimizing the time cells spend outside of the incubator. Perfect coordination of the robotic arms is guaranteed by the platform’s Path Finder™ move optimization technology, which continuously adapts to the changing topography of the workdeck, avoiding the need for laborious programming of individual arm movements, helping to accelerate both set-up and routine system use.

                                    RunSetup_resized.gif

Even complex cell-based assays can be automated using the platform’s FluentControl™ software, freeing researchers to focus on other tasks. Fluent’s built-in touchscreen interface simplifies day-to-day activities by guiding scientists through routine set-up and operation of the system for consistent, reproducible operation. It can provide graphical instructions and prompts for every step of the set-up process, from the number and type of cell plates required to the exact location of compound plates and assay reagents, helping to ensure compliance with SOPs and assay protocols. This is complemented by a PC-based programming environment which offers ‘drag and drop’ protocol development, 3D modeling and contextual checks to ensure rapid, easy scripting. FluentControl also offers straightforward integration and control of a wide range of Tecan and third-party devices, providing user-friendly, walkaway automation of virtually any cell-based assay workflow.

info@tecan.com

Product Fluent™ – the new laboratory automation solution for cell-based assays from Tecan
Company Tecan Group Ltd.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Tecan Group Ltd.
Seestrasse 103, 8708 Männedorf, Switzerland

Tel: +41 44 922 85 85



Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!